Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis
Lavinia Palamiuc, A. Schlagowski, Shyuan T. Ngo, et al.
EMBO Molecular Medicine (2015) Vol. 7, Iss. 5, pp. 526-546
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Neuronal Lipid Metabolism: Multiple Pathways Driving Functional Outcomes in Health and Disease
Timothy J. Tracey, Frederik J. Steyn, Ernst J. Wolvetang, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 330
Energy metabolism in ALS: an underappreciated opportunity?
Tijs Vandoorne, Katrien De Bock, Ludo Van Den Bosch
Acta Neuropathologica (2018) Vol. 135, Iss. 4, pp. 489-509
Open Access | Times Cited: 220
ALS: A bucket of genes, environment, metabolism and unknown ingredients
Mónica Zufiría, Francisco J. Gil‐Bea, Roberto Fernández‐Torrón, et al.
Progress in Neurobiology (2016) Vol. 142, pp. 104-129
Closed Access | Times Cited: 183
The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
Jean‐Philippe Loeffler, Gina Picchiarelli, Luc Dupuis, et al.
Brain Pathology (2016) Vol. 26, Iss. 2, pp. 227-236
Open Access | Times Cited: 170
Skeletal muscle in amyotrophic lateral sclerosis
Jeremy M. Shefner, Antonio Musarò, Shyuan T. Ngo, et al.
Brain (2023) Vol. 146, Iss. 11, pp. 4425-4436
Open Access | Times Cited: 44
Altered mitochondria-associated ER membrane (MAM) function shifts mitochondrial metabolism in amyotrophic lateral sclerosis (ALS)
Delfina Larrea, Kirstin A. Tamucci, Khushbu Kabra, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Modulation of Mitochondria–Endoplasmic Reticulum Contacts (MERCs) by Small Molecules as a New Strategy for Restoring Lipid Metabolism in an Amyotrophic Lateral Sclerosis Model
Mikel Etxebeste-Mitxeltorena, Hector Flores‐Romero, Sandra Ramos-Inza, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 3
Role of the Pyruvate Dehydrogenase Complex in Metabolic Remodeling: Differential Pyruvate Dehydrogenase Complex Functions in Metabolism
Sungmi Park, Jae‐Han Jeon, Byong-Keol Min, et al.
Diabetes & Metabolism Journal (2018) Vol. 42, Iss. 4, pp. 270-270
Open Access | Times Cited: 152
Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1
Margaret O. James, Stephan C. Jahn, Guo Zhong, et al.
Pharmacology & Therapeutics (2016) Vol. 170, pp. 166-180
Open Access | Times Cited: 119
Linking mitochondrial dysfunction, metabolic syndrome and stress signaling in Neurodegeneration
Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2016) Vol. 1863, Iss. 5, pp. 1132-1146
Closed Access | Times Cited: 102
SIRT3 and mitochondrial metabolism in neurodegenerative diseases
Illari Salvatori, Cristiana Valle, Alberto Ferri, et al.
Neurochemistry International (2017) Vol. 109, pp. 184-192
Closed Access | Times Cited: 98
Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia
Raphael S. Peter, Angela Rosenbohm, Luc Dupuis, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 10, pp. 901-908
Closed Access | Times Cited: 97
Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS
Ernesto Manzo, Ileana Lorenzini, Dianne Barrameda, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 94
Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
Tesfaye Wolde Tefera, Karin Borges
Frontiers in Neuroscience (2017) Vol. 10
Open Access | Times Cited: 92
Emerging Links between Lipid Droplets and Motor Neuron Diseases
Giuseppa Pennetta, Michael A. Welte
Developmental Cell (2018) Vol. 45, Iss. 4, pp. 427-432
Open Access | Times Cited: 91
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Pauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, et al.
Brain (2016) Vol. 139, Iss. 4, pp. 1106-1122
Open Access | Times Cited: 89
CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?
Tesfaye Wolde Tefera, Frederik J. Steyn, Shyuan T. Ngo, et al.
Cell & Bioscience (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 85
Amyotrophic Lateral Sclerosis: A Neurodegenerative Motor Neuron Disease With Ocular Involvement
Pilar Rojas, Ana I. Ramı́rez, José A. Fernández‐Albarral, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 83
Skeletal-Muscle Metabolic Reprogramming in ALS-SOD1G93A Mice Predates Disease Onset and Is A Promising Therapeutic Target
Silvia Scaricamazza, I. Salvatori, Giacomo Giacovazzo, et al.
iScience (2020) Vol. 23, Iss. 5, pp. 101087-101087
Open Access | Times Cited: 76
SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells
Caterina Peggion, Valeria Scalcon, Maria Lina Massimino, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 614-614
Open Access | Times Cited: 49
BDNF-dependent modulation of axonal transport is selectively impaired in ALS
Andrew P. Tosolini, James N. Sleigh, Sunaina Surana, et al.
Acta Neuropathologica Communications (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 40
The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
Peter W. Stacpoole, Charles E. McCall
Mitochondrion (2023) Vol. 70, pp. 59-102
Open Access | Times Cited: 30
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis
Diana Piol, Tessa Robberechts, Sandrine Da Cruz
Neuron (2023) Vol. 111, Iss. 9, pp. 1355-1380
Open Access | Times Cited: 26
Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis
Teresa Cunha‐Oliveira, Liliana Montezinho, Rui F. Simões, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 248-248
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top